An early-stage company with Series A funding, Zidan is developing a minimally invasive endoscopic device designed for thoracic surgeons and pulmonologists to treat patients with lung cancer using both manual bronchoscopy and robotics.
Zidan
An early-stage company with Series A funding, Zidan is developing a minimally invasive endoscopic device designed for thoracic surgeons and pulmonologists to treat patients with lung cancer using both manual bronchoscopy and robotics.